The Canadian HIV-HCV Co-infection Guidelines list 53 specific recommendations for:
- Evaluating co-infected patients
- Addressing barriers to care
- Selecting treatments
- Determining treatment timing
- Addressing drug-to-drug interactions.
CTN Postdoctoral Fellow Dr. Malika Sharma writes about the current state of PrEP in Canada and how CTN 303 looks to change the way these HIV prevention drugs are delivered.
Hi everyone! My name is Sonia, and I’m one of the Communications and Knowledge Translation Interns working with the CTN this summer.
Read the full text of Dr. Klein’s speech below. Tribute to Mark Wainberg It’s with great sadness that I stand…
The Resource includes sections about when to begin to include community, who to engage in the process, and how to develop roles and compensate team members.